OCT for glaucoma: Today and tomorrow

Article

Comprehensive analysis helps with diagnosis and follow-up

Spectral-domain optical coherence tomography (SD-OCT) is now an established diagnostic tool for optic nerve diseases such as glaucoma. Since the first studies on glaucomatous eyes were published a decade ago using time-domain OCT (TD-OCT), remarkable advances have been realized.

Today ophthalmologists can use SD-OCT to investigate several parameters in cases with any degree of glaucoma. These are derived from the peripapillary retinal nerve fibre layer (RNFL), the optic nerve head (ONH) and the macular ganglion cells (GC). Comprehensive analysis of these data help the clinician in making the diagnosis and following patients up.

Peripapillary RNFL

Given the already good diagnostic capabilities of TD-OCT, it is not surprising that most studies performed with SD-OCT failed to detect any significant improvement when conventional circular peripapillary scans are used.1–4 The main advantage of SD-OCT is rather the remarkably improved repeatability of RNFL thickness measurements in both healthy and glaucomatous eyes, as shown by a test-retest variability which is half compared to that of TD-OCT.1,5 The main reason for such an improvement is related to the new acquisition protocols.

In the case of Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, California, USA), for example, the instrument does not just scan a circle around the ONH, but provides a tridimensional cube of peripapillary data; the 3.4 mm circular scan is subsequently extracted once the centre of the disc is automatically identified, so that the circle is automatically centred. By doing so the operator reduces the measurement variability typical of TD-OCT, where scan repeatability is strongly influenced by improper location of the circle around the ONH.6

It is important to highlight that the instruments manufactured by the different companies provide different, non-interchangeable measurements. Although only a few studies have directly compared some of these instruments,7,8 the published values clearly show that the algorithms developed by each manufacturer to identify and quantify the RNFL thickness are different. The 360° peripapillary RNFL thickness ranges between 89.8 and 113 microns.1,7–16 None of these measurements are interchangeable with those obtained by TD-OCT.

Compared to TD-OCT, one the main advancements of SD-OCT is represented by the RNFL thickness deviation map, which provides additional spatial and morphologic information about RNFL damage and improves the diagnostic sensitivity for glaucoma detection. Recent studies have demonstrated that the above-mentioned map has significantly higher value for diagnostic purposes compared to the standard circular scan.21,22

Last generation SD-OCT devices also offer the advantage of specifically designed software to assess glaucoma progression.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.